Programmed cell death (PCD) plays an important part in animal development. It is responsible for eliminating the cells between developing digits, for example, and is involved in hollowing out solid structures to create cavities (reviewed in [1,2] ). There are many cases, however, where PCD occurs in developing tissues but its function is unknown. Important examples are seen during the folding, pinching off, and fusion of epithelial sheets during vertebrate morphogenesis, as in the formation of the neural tube and lens vesicle [2]; PCD is an invariable accompaniment to these processes, but it is unclear whether it is required for the processes to occur or is just an unavoidable consequence of them. There is increasing evidence that PCD in animals is mediated by a family of cysteine proteases, known as caspases, which are thought to act in a proteolytic cascade, cleaving one another and key intracellular proteins to kill the cell in a controlled way [3, 4] . Inhibitors of caspases are, therefore, potential tools for studying the roles of PCD during animal development [5, 6] . Here, we show that peptide caspase inhibitors block neural tube closure in explanted chick embryos, suggesting that PCD is required for this crucial developmental process.
Results and discussion
The vertebrate neural tube gives rise to the central nervous system. It develops from the neural plate, which invaginates along the length of the embryo; the folding neural plate generates 'neural folds' at its edges, and these come together and fuse, forming the neural tube, which then separates from the overlying epidermis ( [7] ; Fig. 1a ). We focused our attention on the formation of the chick neural tube at the position along the body axis bounded by somites 1 and 8. Closure of the neural tube begins in this region at around the 8-somite stage and is complete by the 11-12-somite stage [8] . In order to estimate the amount of PCD that normally occurs in the developing chick neural tube in this region, we removed embryos from eggs at various developmental stages and incubated them for 10 minutes at room temperature in acridine orange, to label the dead cells [9] . We then immediately examined the embryos as wholemounts in either a conventional or a confocal fluorescence microscope. Whereas there were few dead cells in the developing neural tube in the region of interest at the 6-and 7-somite stages, there were many at the 8-to 12-somite stages (Fig. 1b) . Although dead cells were seen throughout the developing neural tube, they were concentrated in the neural folds, as described previously for the mouse [10] [11] [12] .
To gain experimental access to the process of neurulation, we removed embryos from their eggs at the 8-somite stage, a time when the neural tube was still open between somites 1 and 8, and cultured them at 37°C for 8 hours in 250 l drops of serum-free medium. At the end of the culture period, we examined the embryos in an inverted phase-contrast microscope to count the somites. Between 70% and 80% of the cultured embryos developed to the expected 12-13-somite stage in this period, and only these embryos were studied further. They were either embedded in O.C.T. compound and frozen in liquid nitrogen or embedded in paraffin. They were then cut into crosssections and stained with either propidium iodide (for frozen sections) or hematoxylin (for paraffin sections). In all of the embryos that developed to the 12-13-somite stage, the neural tube between somites 1 and 8 was completely closed, suggesting that neural tube closure can occur normally in these cultures.
In order to study the role of PCD in neural tube closure, we cultured embryos at the 8-somite stage for 8 hours in the presence of one of the cell-permeable peptide caspase inhibitors benzyloxycarboxyl-Val-Ala-Asp(O-methyl)-fluoromethylketone (zVAD-fmk) [13] or Boc-Asp(Omethyl)-fluoromethylketone (BocD-fmk) [14] , used at a final concentration of 200 M. As a control, embryos were incubated either in the absence of inhibitor or in the presence of the cell-permeable peptide cathepsin-B inhibitor benzyloxycarboxyl-Phe-Ala(O-methyl)-fluoromethylketone (zFA-fmk), at a concentration of 200 M, which would not be expected to inhibit caspases. Again, 70-80% of the embryos developed to the expected 11-12-somite stage in either the presence or the absence of inhibitors, and only these embryos were embedded, sectioned and (Fig. 2a) . In some embryos treated with zVAD-fmk or BocD-fmk, the neural folds were apposed at some points, but in no case were they fused.
To confirm that the caspase inhibitors blocked PCD in the developing neural tube, we cultured 8-somite embryos in the presence or absence of the inhibitors; after 2, 4 and 8 hours, we exposed the embryos to acridine orange for 10 minutes at room temperature and examined them immediately as wholemounts in a fluorescence microscope. In control embryos cultured without inhibitor or in 200 M zFA-fmk, there were many dead cells in the developing neural tube at all time points; in embryos treated with zVAD-fmk or BocD-fmk, there were only rare dead cells in the neural tube at 8 hours (Fig. 2b) , very few at 4 hours, and normal numbers at 2 hours (data not shown). Thus the caspase inhibitors effectively blocked PCD, at least for the last 4 hours of culture.
To check that the caspase inhibitors did not inhibit cell proliferation, we cultured embryos for 8 hours in the presence or absence of the inhibitors and added bromodeoxyuridine (BrdU; 10 M) for the last 2 hours. We then fixed the embryos in paraformaldehyde, cut them into transverse frozen sections, and stained them with a monoclonal anti-BrdU antibody, as well as with propidium iodide to visualize all the nuclei. We counted the proportion of BrdU-labelled nuclei in the neural tube at the level of somite 5. As shown in Figure 3 , there were no significant differences in the numbers of BrdU-labelled cells between the treated and untreated embryos, suggesting that the caspase inhibitors did not inhibit cell proliferation in the developing neural tube. As expected, pyknotic cells were rarely seen in the neural tube at this level in sections of embryos treated with the caspase inhibitors, whereas there were 3-10 pyknotic cells per section in embryos that were untreated and 10-30 pyknotic cells per section in embryos that were treated with zFA-fmk ( Fig. 2c and data not shown). It is not clear why treatment with zFA-fmk increased PCD in the neural tube.
We cannot exclude the possibility either that the caspase inhibitors block neural tube formation by an effect on a process other than PCD, or that the 'undead' cells saved by the inhibitors are somehow abnormal and so interfere with neural tube closure. The most likely interpretation of our results, however, is that PCD is required for neural tube closure, at least in the region of chick neural tube that we studied. It is uncertain what role PCD plays in the process of neural tube closure; in principle, cell death could help in the rolling up and coming together of the neural folds, in the fusion of the folds, or in the separation of the neural tube from the overlying epidermis. In some embryos that were treated with caspase inhibitors for 8 hours, the neural folds remained widely separated, whereas in others they were touching at the midline at multiple points; in no case were the folds fused. Because of this variability and the uncertainty about precisely when the inhibitors begin to block PCD in the explants, we cannot be certain which aspects of neural tube closure depend on PCD. We favour the view that PCD is at least required for the cell rearrangements that occur in the epithelial sheets when the neural folds fuse, and may, in a similar way, be required wherever epithelial sheets fuse during animal development.
Materials and methods

Peptide inhibitors
All chemicals were from Sigma unless otherwise stated. The peptide caspase inhibitors zVAD-fmk and BocD-fmk, as well as the peptide cathepsin-B inhibitor, zFA-fmk, were purchased from Enzyme Systems Products (Dublin, California) and used at a final concentration of 200 M. Stock solutions of the inhibitors (50 mM) were prepared in dry dimethyl sulphoxide and stored in aliquots at -80°C.
Embryo staging
Eggs of White Leghorn chicks were incubated at 38°C and 55% humidity for 33-40 h in order to obtain embryos ranging from stages 9-11 according to Hamburger and Hamilton [15] . The embryos were staged in ovo by cutting a window in the egg shell, injecting black ink (Tusche A 17, Pelikan) under the embryo for contrast, and counting somites in a dissecting microscope with direct illumination.
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Figure 3
Caspase inhibitors do not affect BrdU incorporation in the developing neural tube in explanted embryos. BrdU was added for the last 2 h of the 8 h culture period, and the embryos were fixed, cut into transverse frozen sections, and the sections at the level of somite 5 were stained with anti-BrdU antibody and propidium iodide. The percentage of nuclei in the developing neural tube that were BrdU-positive was determined using the confocal microscope. The results are shown as the mean ± the standard deviation of at least three sections. 
Embryo cultures
Embryos at the 8-somite stage were removed from their eggs and transferred into a 250 l drop of Neurobasal medium containing B27 supplement and L-glutamine (GIBCO-BRL) in 25 mm culture dishes (Falcon). The embryos were incubated at 37°C in 5% CO 2 for 8 h.
Acridine-orange staining
Dissected embryos were stained with acridine orange (500 pg ml -1 in phosphate buffered saline (PBS); Gurr, London) for 10 min at room temperature. The embryos were then rinsed in PBS, mounted on a glass slide in PBS with their neural tube facing up, sealed with silicone grease under a glass cover slip, and immediately examined in an MRC-1000 laser-scanning fluorescence confocal microscope (Bio-Rad Labs, Hercules, California), using a 10× objective. About 6-12 consecutive 1-2 m optical sections of the neural tube were summed to give single-image projection micrographs.
Paraffin sections
Fresh or cultured embryos were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) at 4°C for 18-48 h, dehydrated in a graded series of ethanols, and cleared in Histo-clear (Fischer Scientific, UK) for at least 2 h. The embryos were then embedded in paraffin, and crosssections (6-10 m) were cut with a microtome. The sections were collected onto gelatin-coated glass slides, rehydrated, stained with hematoxylin (Gill No. 1, Sigma), dehydrated, dried, and mounted under a coverslip in a drop of DPX (Fluka, Switzerland).
Frozen sections and propidium iodide staining
Fresh or cultured embryos were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) at 4°C for 18-48 h and then cryoprotected in 1 M sucrose in the same buffer for 1-2 days. The embryos were then embedded in a 1:1 (v/v) mixture of O.C.T. compound (Miles, Elkhart, Indiana) and 1 M sucrose, gently rocked for 6-8 h at room temperature, and frozen in liquid nitrogen. Frozen sections (6-12 m) were cut in a Bright cryostat, collected onto glass slides coated with 3-aminopropyltriethoxy-silane, gelatin, or Vectabond, and stained with propidium iodide (1 g ml -1 ) as described previously [16] . The stained sections were examined in either a Zeiss Axiophot fluorescence microscope or the confocal fluorescence microscope (as described above), using a 20× or 40× objective.
BrdU incorporation
BrdU was added to a final concentration of 10 M to cultured embryos for the final 2 h of the 8 h culture period. The embryos were then fixed for 2-3 min in cold 4% paraformaldehyde and cut into frozen sections as described above. The sections were permeabilized for 15 min in cold 70% ethanol, rinsed, and then treated with 2 M HCl and then 0.1 M sodium tetraborate pH 7.4, both for 10 min. Sections at the level of somite 5 were stained with the Bu20 mouse monoclonal anti-BrdU antibody [17] (supernatant; diluted 1:1 in PBS) overnight at 4°C, followed by fluorescein-coupled goat anti-mouse immunoglobulin antibodies (Amersham; diluted 1:100) for 1 h at room temperature. The sections were finally labelled with propidium iodide (1g ml -1 ), mounted, and examined in a confocal microscope, as described above. The green (BrdU) and red (propidium iodide) images were merged, and the proportion of BrdUpositive nuclei in each section of neural tube was determined.
